Molecular perspective on targeted therapy in breast cancer: a review of current status.

Demir Cetinkaya, Busra; Biray Avci, Cigir

Demir Cetinkaya, Busra; Biray Avci, Cigir.

Affiliation

Demir Cetinkaya B; Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Erzincan Binali Yildirim University, Erzincan, Turkey.
Biray Avci C; Department of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey. cbavci@gmail.com.

Med Oncol ; 39(10): 149, 2022 Jul 14.

Article in En | MEDLINE | ID: mdl-35834030

Subject(s)

Breast Neoplasms; Breast Neoplasms/drug therapy; Breast Neoplasms/metabolism; Female; Humans; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinases/metabolism; TOR Serine-Threonine Kinases/metabolism

Key words

Breast cancer; CDK4/6 inhibitors; PARP inhibitors; PI3K/Akt/mTOR pathway inhibitors; Targeted therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: Med Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Turkey Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google